Meeting
2014 Gastrointestinal Cancers Symposium
Evaluation of usefulness of Royal Marsden Hospital prognostic index in second-line chemotherapy of advanced gastric cancer.
Authors
Takahide Sasaki
Department of Gastroenterology and Hepatology, Hokkaido University Hospital, Sapporo, Japan
Takahide Sasaki , Yoshito Komatsu , Satoshi Yuki , Kazuaki Harada , Yoshimitsu Kobayashi , Hiraku Fukushima , Naoya Sakamoto
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 32, 2014 (suppl 3; abstr 163)
DOI
10.1200/jco.2014.32.3_suppl.163
Abstract #
163
Poster Bd #
E31
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Prognostic value of mismatch repair deficiency in patients receiving first-line fluoropyrimidine plus platinum chemotherapy for metastatic, recurrent, or locally advanced unresectable gastric cancer.
First Author: Chung Ryul Oh
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The new prognostic index of advanced gastric cancer using the data from JCOG1013.
First Author: Daisuke Takahari
Poster
2019 ASCO Annual Meeting
A phase II, open label, multicenter trial of avelumab in patients with advanced, metastatic high-grade neuroendocrine carcinomas NEC G3 (WHO 2010) progressive after first-line chemotherapy (AVENEC).
First Author: Christian Fottner
Poster
2019 Gastrointestinal Cancers Symposium
Impact of peripheral neuropathy induced by platinum in first-line chemotherapy on second-line chemotherapy containing paclitaxel for advanced gastric cancer.
First Author: Ryo Otsuka